A carregar...
Publicação
Shaping tomorrow´s healthcare technology: a deep dive into philips´ equity
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 3.1 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
This report is an equity valuation of Koninklijke Philips N.V., a
global leader in healthcare technology and based in the
Netherlands. The company has over a century of experience and
operates in 3 business units: Diagnostic and Imaging, Connected
Care and Personal Health. In august 2023, Exor N.V bought a 15%
shareholding in Philips. Therefore, fully supporting Philips’
leadership, strategy, and value creation potential. Philips has to a
two-tier board structure consisting of a Board of Management and
a Supervisory Board. Over the past decade, Philips has
transformed into a high-tech health technology company, focusing
on high-growth healthcare sectors. Their strategic direction
addresses challenges such as an aging population and healthcare
costs, aiming to deliver efficient, data-driven solutions. This
equity report employs a bottom-up approach to estimate market
sizes for Philips. Using product-level sales data, ratios, and
national statistics, the report projects market sizes based on factors
like population, ICU units per inhabitant, and price per ICU unit.
The approach is transparent but relies on simplifying assumptions
detailed in the accompanying Excel file. Market sizes were crosschecked with analyst consensus, and growth geographies were
analyzed using region-wide GDP growth as a proxy for healthcare
spending. Assumptions and methodologies aim to balance
accuracy with practicality.
Descrição
Palavras-chave
Philips Koninklijke philips n.v. Healthcare Healthcare technology